Dr. Thomas Shenk is Professor of Life Sciences, Emeritus, in the Department of Molecular Biology at Princeton University. He is a virologist, who has investigated gene functions and pathogenesis of adenovirus and, more recently, human cytomegalovirus. His laboratory’s interest in host–pathogen interactions led to the discovery that some members of the sirtuin family of proteins are viral restriction factors, leading to the co-founding of Evrys Bio. Tom is a member of the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the American Philosophical Society. He is a past president of the American Society for Virology and the American Society for Microbiology. He served on the board of directors of Merck & Company for 11 years and currently chairs the board of Evrys Bio. Over his career, Tom has published nearly 300 scientific papers and commentaries.
Dr. Thomas Shenk is Professor of Life Sciences, Emeritus, in the Department of Molecular Biology at Princeton University. He is a virologist, who has investigated gene functions and pathogenesis of adenovirus and, more recently, human cytomegalovirus. His laboratory’s interest in host–pathogen interactions led to the discovery that some members of the sirtuin family of proteins are viral restriction factors, leading to the co-founding of Evrys Bio. Tom is a member of the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the American Philosophical Society. He is a past president of the American Society for Virology and the American Society for Microbiology. He served on the board of directors of Merck & Company for 11 years and currently chairs the board of Evrys Bio. Over his career, Tom has published nearly 300 scientific papers and commentaries.